Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 1.88%1.63B | 2.11%1.6B | 27.02%1.57B | 13.29%1.24B | 19.03%1.09B | 5.94%916.77M | 10.56%865.37M | 10.98%782.72M | 47.19%705.27M | 234.99%479.15M |
| Revenue from customers | 1.88%1.63B | 1.28%1.6B | 26.89%1.58B | 13.22%1.25B | 22.49%1.1B | 3.97%899.7M | 10.56%865.37M | 10.98%782.72M | 47.19%705.27M | 207.46%479.15M |
| Other cash income from operating activities | ---- | ---- | -12.22%-12.9M | -6.30%-11.5M | -163.38%-10.81M | --17.06M | ---- | ---- | ---- | ---- |
| Cash paid | -2.50%-1.33B | -1.09%-1.3B | -20.03%-1.29B | -22.47%-1.07B | -19.48%-876.05M | 4.40%-733.19M | -11.27%-766.94M | -8.07%-689.23M | -52.65%-637.78M | -224.28%-417.79M |
| Payments to suppliers for goods and services | -2.50%-1.33B | -1.09%-1.3B | -20.03%-1.29B | -22.47%-1.07B | -19.48%-876.05M | 4.40%-733.19M | -11.27%-766.94M | -8.07%-689.23M | -52.65%-637.78M | -224.28%-417.79M |
| Direct interest paid | -7.99%-28.76M | -302.48%-26.63M | -81.41%-6.62M | -39.52%-3.65M | 45.92%-2.61M | -5.55%-4.83M | 0.02%-4.58M | -12.97%-4.58M | -8.05%-4.06M | -559.58%-3.75M |
| Direct interest received | -14.35%889K | 64.50%1.04M | --631K | ---- | -76.36%61K | -44.99%258K | -41.67%469K | -18.46%804K | -16.79%986K | 20.30%1.19M |
| Direct tax refund paid | 19.04%-24.35M | -50.32%-30.07M | -3.01%-20M | 63.51%-19.42M | -331.93%-53.23M | 56.96%-12.32M | -45.75%-28.63M | -3.38%-19.65M | -31.66%-19M | -122.05%-14.43M |
| Operating cash flow | 0.43%247.12M | -4.11%246.05M | 82.83%256.59M | -11.96%140.35M | -4.36%159.41M | 153.74%166.67M | -6.25%65.69M | 54.27%70.07M | 2.39%45.42M | 446.61%44.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -115.52%-73.35M | 15.88%-34.03M | 16.75%-40.46M | -8.81%-48.6M | -36.23%-44.67M | 10.52%-32.79M | -124.56%-36.64M | 70.20%-16.32M | -70.58%-54.75M | 41.55%-32.1M |
| Net PPE purchase and sale | -27.29%-31.62M | 5.26%-24.84M | 32.44%-26.22M | -47.89%-38.81M | -10.09%-26.24M | 4.04%-23.84M | -56.29%-24.84M | 33.46%-15.89M | -48.19%-23.89M | -333.63%-16.12M |
| Net intangibles purchas and sale | -62.59%-11.35M | 14.25%-6.98M | -14.88%-8.14M | -30.53%-7.09M | ---5.43M | ---- | ---- | ---- | ---- | ---- |
| Net business purchase and sale | -1,273.86%-30.38M | 63.74%-2.21M | -125.52%-6.1M | 79.19%-2.7M | -45.16%-13M | 24.15%-8.95M | -2,683.96%-11.8M | 98.61%-424K | -91.37%-30.58M | 68.35%-15.98M |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---288K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -115.52%-73.35M | 15.88%-34.03M | 16.75%-40.46M | -8.81%-48.6M | -36.23%-44.67M | 10.52%-32.79M | -124.56%-36.64M | 70.20%-16.32M | -70.58%-54.75M | 41.55%-32.1M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 24.67%-160.98M | 9.22%-213.71M | -209.59%-235.42M | 44.01%-76.04M | -17.87%-135.81M | -278.29%-115.22M | 49.46%-30.46M | -673.80%-60.27M | 459.62%10.5M | -96.91%1.88M |
| Net issuance payments of debt | -1,200.00%-11M | 105.00%1M | -129.04%-20M | 359.17%68.88M | --15M | --0 | 142.37%12.5M | -173.75%-29.5M | 211.28%40M | -176.80%-35.94M |
| Net common stock issuance | --60.45M | ---- | ---- | -69.49%310K | 20.38%1.02M | -52.66%844K | 7.22%1.78M | -40.80%1.66M | -95.40%2.81M | 135.75%61.13M |
| Cash dividends paid | 28.20%-56.6M | 10.39%-78.83M | -182.34%-87.97M | 52.08%-31.16M | -33.35%-65.02M | -8.98%-48.76M | -37.17%-44.74M | -0.18%-32.62M | -37.88%-32.56M | -96.49%-23.62M |
| Net other financing activities | 43.30%-153.83M | -6.45%-271.32M | -12.21%-254.89M | -30.84%-227.15M | -28.97%-173.61M | ---134.61M | ---- | -28.13%184K | -17.95%256K | --312K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 24.67%-160.98M | 9.22%-213.71M | -209.59%-235.42M | 44.01%-76.04M | -17.87%-135.81M | -278.29%-115.22M | 49.46%-30.46M | -673.80%-60.27M | 459.62%10.5M | -96.91%1.88M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.62%28.05M | -40.24%29.72M | 45.92%49.73M | -37.93%34.08M | 49.63%54.91M | -5.35%36.7M | -15.13%38.77M | 2.49%45.68M | 48.63%44.57M | 86.52%29.99M |
| Current changes in cash | 856.51%12.79M | 91.24%-1.69M | -222.81%-19.29M | 174.53%15.71M | -212.93%-21.07M | 1,417.73%18.66M | 78.29%-1.42M | -656.96%-6.52M | -91.72%1.17M | 1.62%14.14M |
| Effect of exchange rate changes | -6,810.53%-1.28M | 102.62%19K | -1,216.36%-724K | -122.54%-55K | 154.83%244K | 32.37%-445K | -69.59%-658K | -525.81%-388K | -113.90%-62K | --446K |
| End cash Position | 41.03%39.56M | -5.62%28.05M | -40.24%29.72M | 45.92%49.73M | -37.93%34.08M | 49.63%54.91M | -5.35%36.7M | -15.13%38.77M | 2.49%45.68M | 48.63%44.57M |
| Free cash from | -4.71%204.14M | -3.60%214.23M | 135.29%222.23M | -26.06%94.45M | -10.57%127.74M | 249.69%142.84M | -24.55%40.85M | 151.42%54.14M | -23.74%21.53M | 596.40%28.24M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |